May 23: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
FEisenberg (talk | contribs)
No edit summary
FEisenberg (talk | contribs)
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
== May 23 QRPH Face-to-Face Meeting Minutes ==
== May 23 QRPH Face-to-Face Meeting Minutes ==
Attendees:
Attendees:
Floyd Eisenberg (Siemens)
* Floyd Eisenberg (Siemens)
Jason Colquit (Greenway Medical Systems)
* Jason Colquit (Greenway Medical Systems)
Sheila Teasdale (AMA)
* Sheila Teasdale (AMA)
Delane Heldt (AMA)
* Delane Heldt (AMA)
Harry Solomon (GE)
* Harry Solomon (GE)
Patty Craig (Joint Commission)
* Patty Craig (Joint Commission)
Jan Orton (Intermountain Healthcare)
* Jan Orton (Intermountain Healthcare)
Randolph Barrows (MedAllies)
* Randolph Barrows (MedAllies)
Daemon Whittenberg (Greenway Medical Systems)
* Daemon Whittenberg (Greenway Medical Systems)
Joann Larson (Kaiser)
* Joann Larson (Kaiser)
Ana Estelrich (GMP-DIP)
* Ana Estelrich (GMP-DIP)
Chris Carr (RSNA)
* Chris Carr (RSNA)


# Clinical Research Profile
# Clinical Research Profile
Line 24: Line 24:
## At risk June 9
## At risk June 9
# White paper
# White paper
## Updated White Paper with content based on discussions of May 19-23 inclusive: [ftp://ftp.ihe.net/Quality/2008_2009_YR_2/Technical/26_04_2008_IHE_QRPH_White_Paper_Performance_Measure_Data_Element_Structured_for_EHR_Extraction.doc White paper]
## Requires 2 calls
## Requires 2 calls

Latest revision as of 15:55, 19 June 2008

May 23 QRPH Face-to-Face Meeting Minutes

Attendees:

  • Floyd Eisenberg (Siemens)
  • Jason Colquit (Greenway Medical Systems)
  • Sheila Teasdale (AMA)
  • Delane Heldt (AMA)
  • Harry Solomon (GE)
  • Patty Craig (Joint Commission)
  • Jan Orton (Intermountain Healthcare)
  • Randolph Barrows (MedAllies)
  • Daemon Whittenberg (Greenway Medical Systems)
  • Joann Larson (Kaiser)
  • Ana Estelrich (GMP-DIP)
  • Chris Carr (RSNA)
  1. Clinical Research Profile
    1. “Other option” requires review – Send to QRPH TC – Schedule one call
  2. Drug Safety Profile
    1. Pull content from Clinical Research Profile
    2. E2B describes data elements
      1. How to describe what was the adverse event
      2. Need to identify the information to be send and how based on the trigger
    3. Calls
    4. At risk June 9
  3. White paper
    1. Updated White Paper with content based on discussions of May 19-23 inclusive: White paper
    2. Requires 2 calls